
  
    
      
        Background_NNP
        Over_IN the_DT last_JJ 50_CD years_NNS ,_, the_DT widespread_JJ usage_NN of_IN
        fluoridated_JJ water_NN and_CC fluoridated_JJ dentrifices_NNS have_VBP been_VBN
        cited_VBN as_IN major_JJ reasons_NNS for_IN a_DT decline_NN in_IN caries_NNS since_IN the_DT
        early_JJ 1970_CD s_VBZ [_NN 1_CD ]_NN ,_, and_CC for_IN the_DT appearance_NN of_IN a_DT significant_JJ
        association_NN between_IN oral_JJ hygiene_NN and_CC caries_NNS experience_VBP [_NN 2_CD
        3_CD 4_CD ]_NN ._. An_DT inverse_NN relationship_NN exists_VBZ between_IN salivary_JJ
        fluoride_NN concentration_NN and_CC caries_NNS experience_VBP in_IN the_DT
        deciduous_JJ and_CC permanent_JJ dentition_NN [_NN 5_CD ]_NN ,_, but_CC fluoride_NN
        concentration_NN is_VBZ excluded_VBN from_IN most_JJS caries_NNS prediction_NN
        models_NNS [_NN 6_CD 7_CD ]_NN ._. Acids_NNP in_IN bacterial_JJ plaques_NNS cause_VBP caries_NNS in_IN
        pits_NNS ,_, fissures_NNS and_CC interdental_NN regions_NNS of_IN teeth_NNS ,_, but_CC they_PRP
        also_RB enhance_VB the_DT inhibitory_NN effect_NN of_IN fluoride_NN on_IN
        demineralization_NN ,_, confounding_VBG the_DT ability_NN to_TO predict_VB caries_NNS
        from_IN the_DT salivary_JJ fluoride_NN concentration_NN [_NN 8_CD 9_CD ]_NN ._.
        The_DT greater_JJR the_DT consumption_NN of_IN dietary_JJ sucrose_NN ,_, the_DT
        greater_JJR the_DT fall_NN in_IN pH_NN and_CC fraction_NN of_IN acidogenic_JJ ,_, acid_NN
        tolerant_NN bacteria_NNS in_IN tooth_NN adherent_NN plaques_NNS [_NN 10_CD 11_CD ]_NN ._. The_DT
        number_NN of_IN these_DT bacteria_NNS (_( mostly_RB mutans_NNS streptococci_NN and_CC
        lactobacilli_NN )_) ,_, and_CC the_DT fluoride_NN content_NN ,_, discriminate_JJ
        between_IN severe_JJ and_CC mild_JJ caries_NNS in_IN 12_CD -_: 15_CD year-old_JJ children_NNS [_NN
        12_CD 13_CD ]_NN ._. Acid-tolerant_NNP bacteria_NNS require_VBP D-_NNP alanyl_NN glycerol_NN
        lipoteichoic_JJ acid_NN (_( D-_NNP alanyl_NN LTA_NNP )_) in_IN their_PRP$ membranes_NNS and_CC
        cell_NN surfaces_VBZ [_NN 14_CD ]_NN ._. D-_NNP alanyl_NN LTA_NNP is_VBZ made_VBN by_IN esterifying_VBG
        carboxyl-activated_JJ D-_NNP alanine_NN to_TO glycerol_NN in_IN membrane_NN LTA_NNP by_IN
        means_NNS of_IN a_DT D-_NNP alanyl-carrier_JJ enzyme_NN ,_, DCP_NNP [_NN 15_CD ]_NN ._. Strains_NNP of_IN
        
        Streptococcus_NNP mutans_NNS in_IN which_WDT DCP_NNP is_VBZ
        inactive_JJ do_VBP not_RB initiate_VB growth_NN at_IN below_IN pH_NN 6_CD ._. 5_CD and_CC make_VB
        glycerol_NN LTA_NNP without_IN D-_NNP alanine_NN [_NN 14_CD ]_NN ._. In_IN the_DT DCP_NNP active_JJ
        strains_NNS ,_, soluble_JJ D-A_NNP lanyl_NN LTA_NNP is_VBZ extruded_JJ into_IN culture_NN
        fluid_JJ 
        in_IN vitro_NN [_NN 16_CD 17_CD ]_NN or_CC plaque_NN 
        in_IN vivo_NN [_NN 18_CD ]_NN ._. The_DT D-_NNP alanyl_NN esters_NNS
        are_VBP stable_JJ at_IN pH_NN 6_CD ._. 0_CD at_IN 37_CD °_NN C_NNP ,_, but_CC hydrolyze_NN to_TO free_VB
        D-_NNP alanine_NN and_CC LTA_NNP with_IN a_DT half-life_NN of_IN 3_CD ._. 9_CD h_NN at_IN pH_NN 8_CD ._. 0_CD [_NN 19_CD
        ]_NN ._. Healthy_JJ gingival_NN sulci_NN have_VBP a_DT pH_NN of_IN 6_CD ._. 5_CD -_: 7_CD ._. 5_CD and_CC
        inflamed_JJ sulci_NN a_DT pH_NN of_IN 7_CD ._. 5_CD -_: 8_CD ._. 5_LS [_NN 20_CD ]_NN ._.
        About_IN 30_CD %_NN of_IN young_JJ adults_NNS have_VBP serum_NN IgG_NNP antibodies_NNS that_WDT
        precipitate_NN with_IN D-_NNP alanyl_NN LTA_NNP ,_, but_CC not_RB with_IN D-_NNP alanine-free_JJ
        LTA_NNP [_NN 17_CD 21_CD ]_NN ._. It_PRP is_VBZ likely_JJ that_IN plaques_NNS induce_VB these_DT IgG_NNP
        antibodies_NNS from_IN gingival_NN sulci_NN that_WDT contain_VBP more_RBR
        acid-tolerant_JJ bacteria_NNS ._. An_DT elevated_VBD IgG_NNP antibody_NN response_NN
        to_TO D-_NNP alanyl_NN LTA_NNP may_MD therefore_RB indicate_VB the_DT subjects_NNS in_IN whom_WP
        an_DT inhibitory_NN effect_NN of_IN fluoride_NN on_IN caries_NNS is_VBZ enhanced_VBN ._. The_DT
        fluoride_NN concentrations_NNS of_IN plaque_NN and_CC saliva_NN are_VBP related_VBN to_TO
        whether_IN the_DT drinking_NN water_NN is_VBZ fluoridated_JJ [_NN 13_CD ]_NN and_CC to_TO
        oral_JJ hygiene_NN ,_, which_WDT nearly_RB always_RB involves_VBZ using_VBG a_DT
        fluoridated_JJ dentrifice_NN ._. The_DT aim_NN of_IN this_DT study_NN was_VBD therefore_RB
        to_TO determine_VB whether_IN elevated_JJ antibody_NN responders_NNS to_TO
        D-_NNP alanyl_NN LTA_NNP show_NN a_DT association_NN of_IN DMFT_NNP with_IN fluoride_NN
        exposure_NN and_CC gingival_NN health_NN not_RB apparent_JJ in_IN low_JJ
        responders_NNS ._.
      
      
        Methods_NNP
        
          Subjects_NNP
          Antibody_NNP was_VBD obtained_VBN from_IN blood_NN from_IN four_CD sources_NNS :_: 1_LS )_)
          105_CD dental_JJ students_NNS ,_, 2_LS )_) 147_CD patients_NNS seeking_VBG dental_JJ
          treatment_NN ,_, 3_LS )_) 145_CD volunteer_NN blood_NN donors_NNS (_( volunteers_NNS )_) ,_,
          and_CC 4_LS )_) 37_CD siblings_NNS aged_VBN 5_CD through_IN 25_CD from_IN six_CD Amish_NNP
          families_NNS ._. The_DT dental_JJ students_NNS and_CC patients_NNS were_VBD attending_VBG
          the_DT University_NNP of_IN Oklahoma_NNP Health_NNP Sciences_NNPS Center_NNP between_IN
          1985_CD and_CC 1988_CD ._. The_DT volunteers_NNS and_CC Amish_NNP family_NN members_NNS
          were_VBD attending_VBG centers_NNS elsewhere_RB in_IN the_DT US_NNP at_IN the_DT same_JJ
          time_NN ._. All_DT subjects_NNS consented_VBD to_TO provide_VB blood_NN for_IN
          antibody_NN analysis_NN according_VBG to_TO local_JJ Institutional_NNP Review_NNP
          Board_NNP procedures_NNS (_( see_VB Acknowledgements_NNP )_) ._. The_DT student_NN ,_,
          patient_NN and_CC volunteer_NN populations_NNS (_( 397_CD subjects_NNS )_) were_VBD
          used_VBN to_TO determine_VB what_WP IgG_NNP concentration_NN constituted_VBD an_DT
          elevated_VBD antibody_NN response_NN to_TO D-_NNP alanyl_NN LTA_NNP ,_, to_TO ensure_VB
          that_IN these_DT antibodies_NNS were_VBD not_RB unique_JJ to_TO dental_JJ or_CC
          Oklahoma_NNP populations_NNS and_CC to_TO examine_VB whether_IN the_DT antibody_NN
          concentration_NN was_VBD sex_NN or_CC age-associated_JJ ._. The_DT Amish_NNP family_NN
          siblings_NNS were_VBD selected_VBN to_TO determine_VB the_DT frequency_NN of_IN high_JJ
          antibody_NN concentration_NN in_IN children_NNS and_CC young_JJ adults_NNS ._. Each_DT
          sibling_VBG had_VBN at_IN least_JJS one_CD parent_NN high_JJ responder_NN to_TO
          increase_VB the_DT likelihood_NN of_IN exposure_NN to_TO an_DT
          antibody-associated_JJ oral_JJ microbiota_NN from_IN birth_NN ._.
          The_DT clinical_JJ study_NN participants_NNS consisted_VBD of_IN 87_CD dental_JJ
          students_NNS (_( 88_CD ._. 4_LS %_NN male_JJ )_) and_CC 64_CD patients_NNS (_( 31_CD ._. 3_LS %_NN male_JJ )_) who_WP
          were_VBD medically_RB healthy_JJ ._. All_DT had_VBD 18_CD or_CC more_RBR natural_JJ teeth_NNS
          and_CC were_VBD aged_VBN >_NN 22_CD and_CC <_NN 38_CD years_NNS ._. Of_IN these_DT
          participants_NNS ,_, 67_CD dental_JJ students_NNS and_CC 35_CD patients_NNS provided_VBD
          information_NN that_WDT permitted_VBD an_DT estimate_NN of_IN exposure_NN to_TO
          fluoridated_JJ water_NN :_: residence_NN (_( s_VBZ )_) from_IN birth_NN through_IN age_NN 14_CD
          in_IN the_DT 1980_CD Fluoridation_NNP Census_NNP ._. Subjects_NNP not_RB using_VBG the_DT
          public_JJ water_NN supply_NN ,_, or_CC resident_NN outside_IN of_IN the_DT US_NNP for_IN
          more_JJR than_IN 18_CD months_NNS ,_, were_VBD excluded_VBN ._. Exposure_NNP to_TO water_VB
          fluoridation_NN scored_VBD 1_CD for_IN each_DT of_IN five_CD 3_CD -_: year_NN age_NN
          cohorts_NNS :_: 0_CD -_: 2_CD ,_, 3_CD -_: 5_CD ,_, 6_CD -_: 8_CD ,_, 9_CD -_: 11_CD and_CC 12_CD -_: 14_CD to_TO give_VB a_DT fluoride_NN
          exposure_NN score_NN (_( F_NN Score_NN )_) of_IN 0_CD (_( no_DT exposure_NN )_) to_TO 5_CD
          (_( complete_JJ exposure_NN )_) described_VBD previously_RB [_NN 22_CD ]_NN ._.
          Most_JJS dental_JJ students_NNS had_VBD mild_JJ caries_NNS and_CC gingivitis_NNS
          and_CC most_JJS patients_NNS had_VBD moderate_JJ to_TO severe_JJ caries_NNS and_CC
          gingivitis_NNS ._. Exceptionally_NNP healthy_JJ or_CC exceptionally_RB
          diseased_JJ subjects_NNS were_VBD therefore_RB increased_VBN compared_VBN to_TO a_DT
          similar_JJ number_NN of_IN subjects_NNS obtained_VBN as_IN a_DT random_JJ sample_NN ._.
          This_DT wide_JJ distribution_NN of_IN clinical_JJ measurements_NNS provided_VBD
          more_RBR stable_JJ estimates_NNS (_( narrower_JJR confidence_NN intervals_NNS )_) of_IN
          regression_NN coefficients_NNS (_( β_NN )_) than_IN would_MD be_VB obtained_VBN from_IN a_DT
          similar_JJ number_NN from_IN a_DT random_JJ survey_NN of_IN the_DT general_JJ
          population_NN ._. Regression_NNP lines_NNS are_VBP more_RBR robust_JJ when_WRB a_DT
          greater_JJR range_NN of_IN measurements_NNS is_VBZ used_VBN [_NN 23_CD ]_NN ._.
        
        
          Clinical_NNP measurements_NNS
          Dental_NNP caries_NNS experience_NN was_VBD the_DT number_NN of_IN Decayed_NNP ,_,
          Missing_NNP and_CC Filled_NNP Teeth_NNP (_( DMFT_NNP )_) ,_, excluding_VBG third_JJ molars_NNS
          and_CC teeth_NNS reported_VBD missing_VBG for_IN other_JJ reasons_NNS ._. Decayed_NNP
          teeth_NNS (_( DT_NNP )_) were_VBD also_RB enumerated_JJ separately_RB from_IN missing_VBG
          and_CC filled_VBN teeth_NNS (_( MFT_NNP )_) ._. DT_NNP indicates_VBZ a_DT combination_NN of_IN
          delay_NN in_IN seeking_VBG therapy_NN and_CC faster_JJR development_NN of_IN new_JJ
          cavities_NNS ._. Fluoridated_NNP dentrifice_NN use_NN is_VBZ related_VBN to_TO oral_JJ
          hygiene_NN but_CC not_RB toothbrushing_VBG frequency_NN in_IN adults_NNS aged_VBN as_IN
          in_IN the_DT present_JJ clinical_JJ study_NN [_NN 3_CD ]_NN and_CC young_JJ enough_RB to_TO
          have_VB likely_RB used_VBN fluoridated_JJ dentrifices_NNS from_IN early_JJ
          childhood_NN ._. Sensitive_NNP staining_VBG for_IN plaque_NN accumulation_NN [_NN
          24_CD ]_NN was_VBD therefore_RB used_VBN with_IN measures_NNS of_IN gingivitis_NNS and_CC
          pocket_NN depth_NN at_IN the_DT mesio-buccal_JJ ,_, buccal_NN ,_, disto-lingual_JJ
          and_CC lingual_NN surfaces_VBZ of_IN the_DT six_CD teeth_NNS employed_VBN for_IN the_DT
          simplified_VBN oral_JJ hygiene_NN index_NN [_NN 25_CD ]_NN ,_, substituting_VBG
          adjacent_JJ teeth_NNS as_IN necessary_JJ (_( 24_CD sites_NNS sampled_VBN )_) ._.
          Gingivitis_NNP was_VBD determined_VBN by_IN whether_IN a_DT site_NN bled_VBD
          within_IN 30_CD sec_NN of_IN gentle_JJ probing_VBG ,_, BOP_NNP [_NN 26_CD 27_CD ]_NN and_CC pocket_NN
          depth_NN by_IN measuring_VBG the_DT distance_NN (_( mm_NN )_) from_IN the_DT free_JJ
          gingival_NN margin_NN to_TO the_DT base_NN of_IN the_DT sulcus_JJ or_CC pocket_NN ._.
          Finally_RB ,_, each_DT subject_NN was_VBD asked_VBN to_TO suck_NN an_DT erythrosin_NN
          tablet_NN for_IN 30_CD sec_NN and_CC the_DT sites_NNS examined_VBD for_IN stained_JJ
          plaque_NN [_NN 24_CD ]_NN ._. For_IN each_DT subject_NN ,_, the_DT mean_NN prevalences_NNS of_IN
          plaque_NN (_( PL_NNP )_) and_CC bleeding_VBG on_IN probing_VBG (_( BOP_NNP )_) ,_, and_CC the_DT mean_JJ
          pocket_NN depth_NN (_( PD_NNP )_) ,_, were_VBD calculated_VBN across_IN all_DT sampled_VBN
          sites_NNS ._. The_DT clinical_JJ measurements_NNS were_VBD made_VBN by_IN two_CD
          experienced_VBN clinicians_NNS who_WP were_VBD calibrated_VBN for_IN this_DT
          study_NN ._. The_DT clinicians_NNS agreed_VBD strongly_RB with_IN respect_NN to_TO all_DT
          measurements_NNS (_( correlation_NN coefficients_NNS ,_, r_LS >_NN 0_CD ._. 85_CD ;_: p_NN
          <_NN 0_CD ._. 001_CD )_) except_IN gingival_NN bleeding_VBG index_NN ,_, for_IN which_WDT a_DT
          weaker_JJR correlation_NN was_VBD noted_VBN (_( r_LS =_SYM 0_CD ._. 60_CD ,_, p_NN <_NN 0_CD ._. 001_CD )_) ._.
          The_DT data_NNS reported_VBD are_VBP the_DT mean_NN measurements_NNS from_IN the_DT
          clinical_JJ examiners_NNS ._.
        
        
          Antigen_NNP purification_NN
          D-_NNP alanyl_NN LTA_NNP ,_, but_CC not_RB D-_NNP alanine-free_JJ LTA_NNP ,_, is_VBZ present_JJ
          in_IN culture_NN filtrates_NNS of_IN 
          Streptococcus_NNP mutans_NNS GS_NNP 5_CD [_NN 17_CD ]_NN ._.
          Bacteria_NNP were_VBD grown_VBN at_IN 37_CD °_NN C_NNP in_IN trypticase_NN soy_NN broth_NN to_TO
          late_JJ stationary_JJ phase_NN (_( 96_CD h_NN )_) ,_, when_WRB the_DT maximal_NN amount_NN of_IN
          antigen_NN is_VBZ extruded_JJ into_IN the_DT culture_NN fluid_JJ [_NN 18_CD ]_NN ._. After_IN
          centrifugation_NN to_TO remove_VB the_DT bacteria_NNS ,_, culture_NN fluid_JJ (_( 10_CD
          1_LS )_) was_VBD concentrated_VBN 20_CD -_: fold_VB over_IN a_DT YM_NNP 10_CD Diaflo_NNP Membrane_NNP
          filter_NN (_( Amicon_NNP Corp_NNP ._. ,_, Beverley_NNP ,_, MA_NNP )_) ._. D-A_NNP lanyl_NN LTA_NNP in_IN the_DT
          concentrate_NN was_VBD detected_VBN by_IN immunoelectrophoresis_NNS ,_, using_VBG
          a_DT standard_JJ human_JJ serum_NN identified_VBN previously_RB [_NN 16_CD ]_NN ._.
          D-A_NNP lanine-free_JJ LTA_NNP does_VBZ not_RB react_VB with_IN this_DT serum_NN IgG_NNP [_NN
          17_CD 18_CD 21_CD ]_NN ._. The_DT D-_NNP alanyl_NN LTA_NNP was_VBD purified_JJ by_IN passing_VBG the_DT
          concentrated_VBN culture_NN fluid_JJ over_IN a_DT 90_CD ×_NN 2_CD ._. 5_CD cm_NN Sephacryl_NNP
          column_NN in_IN 0_CD ._. 4_CD M_NNP NaCl_NNP buffered_JJ with_IN 0_CD ._. 05_CD M_NNP sodium_NN acetate_NN
          pH_NN 5_CD ._. Antigen_NNP in_IN the_DT fractions_NNS was_VBD collected_VBN ._. After_IN
          equilibrating_VBG with_IN 5_CD mM_NN sodium_NN acetate_NN buffer_NN pH_NN 5_CD ._. 0_CD ,_, it_PRP
          bound_VBN to_TO a_DT short_JJ Sephacryl_NNP S-_NNP 200_CD and_CC eluted_JJ by_IN adding_VBG 14_CD
          mM_NN NaCl_NNP as_IN described_VBN previously_RB [_NN 16_CD ]_NN ._.
        
        
          Measuring_NN antibody_NN content_NN and_CC determining_VBG high_JJ and_CC
          low_JJ responders_NNS
          IgG_NNP antibody_NN content_NN was_VBD measured_VBN by_IN
          enzyme-immunoassay_JJ employing_VBG a_DT Fast_NNP Assay_NNP Screening_NNP Test_NNP
          System_NNP at_IN room_NN temperature_NN [_NN 28_CD ]_NN ._. Pegs_NNP protruding_VBG from_IN
          a_DT lid_NN were_VBD placed_VBN over_IN a_DT 96_CD -_: well_RB plate_NN or_CC trough_NN
          containing_VBG 14_CD ml_NN of_IN 10_CD μg_NN /_NN ml_NN D-_NNP alanyl_NN LTA_NNP in_IN acetate_NN
          buffer_NN pH_NN 5_CD for_IN 2_CD h_NN (_( Becton_NNP Dickinson_NNP ,_, Lincoln_NNP Park_NNP ,_, NJ_NNP )_) ._.
          The_DT pegs_VBZ were_VBD blocked_VBN with_IN 14_CD ml_NN of_IN phosphate_NN buffered_JJ
          saline_NN (_( PBS_NNP )_) pH_NN 7_CD ._. 0_CD in_IN 1_CD ._. 0_CD %_NN Tween-_NNP 20_CD and_CC immersed_VBN in_IN
          wells_NNS containing_VBG 0_CD ._. 1_CD ml_NN serum_NN ._. After_IN overnight_JJ
          incubation_NN ,_, excess_JJ IgG_NNP antibody_NN from_IN the_DT serum_NN was_VBD washed_VBN
          away_RB by_IN thrice_NN transferring_VBG the_DT pegs_VBZ to_TO troughs_NNS
          containing_VBG 14_CD ml_NN of_IN PBS_NNP containing_VBG 0_CD ._. 05_CD %_NN Tween_NNP 20_CD
          (_( PBS-Tween_NNP )_) for_IN 5_CD min_NN each_DT time_NN ._. The_DT pegs_VBZ were_VBD then_RB
          immersed_VBN for_IN 2_CD h_NN in_IN a_DT trough_NN containing_VBG 14_CD ml_NN of_IN
          anti-human_JJ IgG_NNP F_NNP (_( ab_NN '_'' 2_LS )_) fragment_NN conjugated_JJ to_TO alkaline_NN
          phosphatase_NN in_IN PBS-Tween_NNP and_CC developed_VBN with_IN nitrophenyl_NN
          phosphate_NN (_( Sigma_NNP Chemical_NNP Co_NNP ._. St_NNP Louis_NNP ,_, MO_NNP )_) ._.
          The_DT concentration_NN of_IN antigen-specific_JJ IgG_NNP in_IN standard_JJ
          serum_NN was_VBD obtained_VBN by_IN measuring_VBG the_DT optimal_NN amount_NN of_IN
          protein_NN immunoprecipitated_JJ [_NN 16_CD ]_NN ,_, and_CC a_DT standard_JJ curve_NN
          of_IN absorbance_NN against_IN concentration_NN was_VBD obtained_VBN (_( Fig_NNP ._.
          1_LS )_) ._. The_DT greatest_JJS range_NN of_IN absorbance_NN occurred_VBD when_WRB sera_NN
          were_VBD measured_VBN at_IN a_DT dilution_NN of_IN 1_CD :_: 200_CD [_NN 28_CD ]_NN ._. Replicate_NNP
          antibody_NN assays_NNS were_VBD performed_VBN on_IN each_DT serum_NN and_CC the_DT
          concentrations_NNS read_VBP off_RP the_DT standard_JJ curve_NN ._. The_DT antibody_NN
          concentrations_NNS are_VBP shown_VBN ranked_VBN in_IN Fig_NNP ._. 2_LS ._.
        
        
          Data_NNP analyses_NNS
          The_DT amount_NN of_IN IgG_NNP antibody_NN to_TO D-_NNP alanyl_NN LTA_NNP varies_VBZ with_IN
          no_DT obvious_JJ cutoff_NN (_( Fig_NNP ._. 2_LS )_) ._. However_RB ,_, the_DT sera_NN containing_VBG
          precipitating_VBG antibody_NN should_MD tend_VB to_TO have_VB high_JJ IgG_NNP
          antibody_NN contents_NNS ._. The_DT IgG_NNP antibody_NN measurements_NNS were_VBD
          alternatively_RB divided_VBN into_IN clusters_NNS ,_, using_VBG the_DT unweighted_JJ
          pair_NN group_NN method_NN with_IN arithmetic_NN averages_NNS [_NN 29_CD ]_NN and_CC
          NT-SYS_NNP ,_, a_DT package_NN of_IN multivariate_NN statistical_JJ computer_NN
          programs_NNS [_NN 30_CD ]_NN ._. A_DT low_JJ response_NN supremum_NN was_VBD obtained_VBN by_IN
          taking_VBG the_DT antilog_NN of_IN the_DT mean_NN IgG_NNP content_NN of_IN the_DT
          non-precipitating_JJ sera_NN plus_CC one_CD standard_JJ deviation_NN ,_, or_CC
          the_DT antilog_NN of_IN the_DT highest_JJS IgG_NNP content_NN of_IN the_DT cluster_NN
          grouping_VBG containing_VBG the_DT least_JJS antibody_NN ._.
          The_DT effect_NN of_IN age_NN was_VBD determined_VBN after_IN splitting_NN the_DT
          subjects_NNS into_IN decile_NN cohorts_NNS (_( Table_NNP 1_LS )_) and_CC comparing_VBG the_DT
          fraction_NN of_IN high_JJ antibody_NN responders_NNS in_IN each_DT cohort_NN ._. The_DT
          youngest_JJS cohort_NN was_VBD composed_VBN of_IN Amish_NNP family_NN siblings_NNS who_WP
          were_VBD younger_JJR than_IN any_DT dental_JJ students_NNS ,_, patients_NNS or_CC
          volunteers_NNS ._.
          A_DT multiple_JJ linear_JJ regression_NN procedure_NN was_VBD utilized_JJ to_TO
          examine_VB the_DT relationship_NN of_IN caries_NNS (_( DMFT_NNP )_) with_IN age_NN ,_, F_NN
          score_NN ,_, and_CC measures_NNS of_IN gingival_NN health_NN obtained_VBN in_IN this_DT
          study_NN :_: PL_NNP ,_, BOP_NNP ,_, and_CC PD_NNP ._. The_DT regression_NN on_IN DMFT_NNP was_VBD used_VBN :_:
          1_LS )_) to_TO estimate_VB the_DT partial_JJ regression_NN coefficients_NNS (_( β_NN
          coefficients_NNS )_) within_IN the_DT high_JJ and_CC low_JJ antibody_NN response_NN
          group_NN ;_: 2_LS )_) to_TO test_VB each_DT β_NN coefficient_NN for_IN significance_NN
          after_IN accounting_VBG for_IN the_DT effects_NNS of_IN the_DT other_JJ four_CD
          variables_NNS ;_: and_CC 3_LS )_) to_TO examine_VB for_IN significant_JJ differences_NNS
          in_IN β_NN coefficients_NNS between_IN the_DT antibody_NN response_NN groups_NNS ._. A_DT
          β_NN coefficient_NN is_VBZ interpreted_VBN as_IN the_DT change_NN in_IN disease_NN
          response_NN (_( DMFT_NNP )_) per_IN unit_NN change_NN in_IN one_CD of_IN the_DT independent_JJ
          variables_NNS after_IN adjusting_VBG for_IN all_PDT the_DT other_JJ independent_JJ
          variables_NNS in_IN the_DT model_NN ._. Within_IN each_DT antibody_NN response_NN
          group_NN ,_, the_DT multiple_JJ regression_NN coefficient_NN (_( R_NN 2_LS )_) provided_VBD
          an_DT estimate_NN of_IN the_DT proportion_NN of_IN variance_NN in_IN DMFT_NNP
          explained_VBN by_IN the_DT combination_NN of_IN variables_NNS tested_VBN ._.
          Stepwise_NNP regression_NN then_RB identified_VBD the_DT best_JJS estimate_NN of_IN
          the_DT variance_NN in_IN DMFT_NNP that_WDT was_VBD explained_VBN by_IN multiple_JJ
          variables_NNS in_IN the_DT separate_JJ and_CC combined_VBN high_JJ and_CC low_JJ
          responder_NN groups_NNS ._. These_DT multiple_JJ regression_NN analyses_NNS were_VBD
          repeated_VBN using_VBG gingivitis_NNS (_( BOP_NNP )_) as_IN the_DT dependent_JJ variable_JJ
          and_CC OHPI_NNP ,_, PD_NNP ,_, DT_NNP and_CC MFT_NNP and_CC age_NN as_IN independent_JJ
          variables_NNS ._. All_DT of_IN the_DT clinically_RB examined_VBN subjects_NNS were_VBD
          included_VBN because_IN F_NN score_NN was_VBD not_RB an_DT independent_JJ variable_NN
          for_IN BOP_NNP ._.
          To_TO ensure_VB that_WDT obtained_VBD relationships_NNS were_VBD robust_JJ ,_,
          influential_JJ points_NNS (_( outliers_NNS )_) were_VBD identified_VBN using_VBG a_DT
          statistic_NN (_( DFFITS_NNP )_) which_WDT measured_VBD the_DT change_NN in_IN
          coefficients_NNS caused_VBN by_IN removing_VBG the_DT data_NNS for_IN each_DT
          subject_NN ._. If_IN this_DT change_NN exceeded_VBD 2_CD √_NN (_( p_NN /_NN n_NN )_) ,_, where_WRB p_NN was_VBD the_DT
          number_NN of_IN independent_JJ variables_NNS and_CC n_NN the_DT number_NN of_IN
          samples_NNS [_NN 31_CD ]_NN ,_, the_DT point_NN was_VBD influential_JJ ._. Repeating_NNP the_DT
          regressions_NNS with_IN all_PDT the_DT influential_JJ points_NNS removed_VBN
          determined_VBD the_DT degree_NN to_TO which_WDT these_DT points_NNS had_VBD affected_VBN
          the_DT results_NNS ._.
        
      
      
        Results_NNS
        
          Definition_NNP of_IN high_JJ antibody_NN response_NN
          IgG_NNP antibodies_NNS were_VBD initially_RB detected_VBN in_IN sera_NN
          irrespective_RB of_IN whether_IN D-_NNP alanyl_NN LTA_NNP was_VBD
          immunoprecipitated_JJ ._. Excluding_VBG the_DT Amish_NNP family_NN group_NN ,_,
          there_EX were_VBD 288_CD subjects_NNS whose_WP$ sera_NN failed_VBD to_TO
          immunoprecipitate_NN antigen_NN (_( detected_VBN by_IN
          immunoelectrophoresis_NNS )_) ._. The_DT mean_NN IgG_NNP antibody_NN
          concentration_NN (_( log_VB ng_NN /_NN ml_NN )_) was_VBD 3_CD ._. 19_CD (_( 0_CD ._. 64_CD standard_JJ
          deviation_NN ,_, s_VBZ ._. d_SYM ._. )_) compared_VBN with_IN 4_CD ._. 25_CD (_( 0_CD ._. 57_CD s_VBZ ._. d_SYM ._. )_) for_IN 109_CD
          subjects_NNS whose_WP$ sera_NN did_VBD precipitate_NN antigen_NN (_( '_POS t_NN '_'' test_NN p_NN
          <_NN 10_CD -_: 6_CD )_) ._. High_JJ responders_NNS therefore_RB had_VBD a_DT log_NN antibody_NN
          content_NN (_( ng_NN /_NN ml_NN )_) that_WDT exceeded_VBD the_DT mean_NN plus_CC standard_JJ
          deviation_NN of_IN non-precipitating_JJ serum_NN (_( log_VB ng_NN IgG_NNP /_NN ml_NN
          >_NN 3_CD ._. 83_CD )_) ._. However_RB ,_, low_JJ IgG_NNP concentrations_NNS formed_VBD a_DT
          cluster_NN whose_WP$ supremum_NN (_( log_VB ng_NN IgG_NNP antibody_NN /_NN ml_NN )_) was_VBD
          3_CD ._. 861_CD ,_, which_WDT corresponds_NNS to_TO 7_CD ._. 26_CD μg_NN /_NN ml_NN (_( left_VBD side_NN of_IN Fig_NNP ._.
          2_LS )_) ._. Subjects_NNP were_VBD therefore_RB classified_VBN as_IN low_JJ responders_NNS
          if_IN their_PRP$ log_NN IgG_NNP antibody_NN content_NN exceeded_VBD 3_CD ._. 86_CD rather_RB
          than_IN 3_CD ._. 83_CD ._. The_DT odds_NNS ratio_NN for_IN a_DT serum_NN from_IN a_DT high_JJ
          antibody_NN responder_NN immunoprecipitating_VBG D-_NNP alanyl_NN LTA_NNP was_VBD
          14_CD times_NNS greater_JJR than_IN for_IN a_DT low_JJ responder_NN ._.
        
        
          High_JJ antibody_NN response_NN ,_, age_NN and_CC gender_NN
          Of_IN the_DT 397_CD students_NNS ,_, patients_NNS and_CC volunteers_NNS ,_, 16_CD did_VBD
          not_RB have_VB their_PRP$ age_NN recorded_VBN ._. High_JJ responders_NNS had_VBD a_DT mean_JJ
          age_NN of_IN 32_CD ._. 7_CD years_NNS ±_NN 9_CD ._. 4_CD s_VBZ ._. d_SYM ._. (_( 136_CD subjects_NNS )_) and_CC low_JJ
          responders_NNS a_DT mean_JJ age_NN of_IN 33_CD ._. 0_CD years_NNS ±_NN 10_CD ._. 7_CD s_VBZ ._. d_SYM ._. (_( 245_CD
          subjects_NNS )_) ._. Table_NNP 1_CD shows_VBZ the_DT fraction_NN of_IN high_JJ responders_NNS
          in_IN different_JJ age_NN cohorts_NNS ._. There_EX was_VBD a_DT high_JJ responder_NN
          frequency_NN of_IN 35_CD -_: 40_CD %_NN from_IN age_NN 15_CD through_IN 54_CD ._. The_DT reduced_VBN
          frequencies_NNS of_IN high_JJ response_NN in_IN childhood_NN and_CC old_JJ age_NN
          were_VBD not_RB significant_JJ ._. However_RB ,_, within_IN the_DT Amish_NNP family_NN
          offspring_NN high_JJ IgG_NNP responders_NNS were_VBD significantly_RB older_JJR ._.
          Table_NNP 2_CD shows_VBZ that_IN the_DT high_JJ responder_NN offspring_NN had_VBD a_DT mean_JJ
          age_NN of_IN 17_CD ._. 1_LS years_NNS compared_VBN with_IN 13_CD ._. 3_LS years_NNS for_IN low_JJ
          responders_NNS ._. This_DT significant_JJ difference_NN (_( '_POS t_NN '_'' statistic_NN =_SYM
          2_CD ._. 42_CD ,_, degrees_NNS of_IN freedom_NN ,_, d_SYM ._. f_SYM ._. =_SYM 35_CD ;_: p_NN <_NN 0_CD ._. 03_CD )_) was_VBD due_JJ
          to_TO few_JJ high_JJ responder_NN children_NNS and_CC young_JJ teenagers_NNS and_CC a_DT
          slightly_RB greater_JJR fraction_NN of_IN siblings_NNS aged_VBN 15_CD -_: 25_CD years_NNS
          who_WP were_VBD high_JJ responders_NNS (_( 50_CD %_NN )_) compared_VBN with_IN the_DT general_JJ
          population_NN ._.
          High_JJ antibody_NN responders_NNS accounted_VBD for_IN a_DT similar_JJ
          fraction_NN of_IN subjects_NNS irrespective_RB of_IN whether_IN they_PRP were_VBD in_IN
          the_DT clinical_JJ study_NN ,_, or_CC dental_JJ students_NNS ,_, or_CC patients_NNS
          (_( Table_NNP 3_LS )_) ._. Men_NN were_VBD 49_CD ._. 1_LS %_NN of_IN the_DT 395_CD students_NNS patients_NNS
          and_CC volunteers_NNS whose_WP$ sex_NN was_VBD recorded_VBN ._. Men_NN had_VBD also_RB a_DT
          greater_JJR frequency_NN of_IN high_JJ response_NN 40_CD ._. 21_CD %_NN vs_NNS 31_CD ._. 34_CD %_NN and_CC a_DT
          greater_JJR mean_NN log_VB ng_NN /_NN ml_NN IgG_NNP antibody_NN content_NN ,_, 3_CD ._. 52_CD ±_NN 0_CD ._. 76_CD
          standard_JJ deviation_NN (_( s_VBZ ._. d_SYM ._. )_) vs_NNS 3_CD ._. 44_CD ±_NN 0_CD ._. 80_CD s_VBZ ._. d_SYM ._. Neither_DT of_IN
          these_DT differences_NNS were_VBD significant_JJ (_( X_NNP 2_CD =_SYM 3_CD ._. 00_CD ,_, p_NN =_SYM 0_CD ._. 09_CD ;_:
          '_POS t_NN '_'' statistic_NN =_SYM 0_CD ._. 34_CD ,_, p_NN =_SYM 0_CD ._. 73_CD )_) ._. In_IN serum_NN samples_NNS from_IN 18_CD
          subjects_NNS aged_VBN between_IN 22_CD and_CC 38_CD ,_, the_DT IgG_NNP antibody_NN
          concentrations_NNS were_VBD essentially_RB the_DT same_JJ after_IN 6_CD months_NNS
          as_RB originally_RB estimated_VBN (_( squared_VBN correlation_NN coefficient_NN ,_,
          R_NN 2_CD >_NN 0_CD ._. 95_CD ,_, p_NN <_NN 0_CD ._. 01_CD )_) ._. The_DT results_NNS indicate_VBP that_IN ,_, for_IN
          subjects_NNS aged_VBN 15_CD -_: 55_CD ,_, age_NN and_CC sex_NN had_VBD little_JJ effect_NN on_IN
          the_DT frequency_NN of_IN high_JJ D-_NNP alanyl_NN LTA_NNP antibody_NN response_NN ._.
        
        
          Association_NNP of_IN DMFT_NNP with_IN gingival_NN health_NN and_CC
          fluoride_NN in_IN high_JJ and_CC low_JJ responders_NNS
          Table_NNP 4_CD lists_NNS the_DT variables_NNS tested_VBN for_IN association_NN with_IN
          DMFT_NNP and_CC the_DT observed_VBN β_NN coefficients_NNS in_IN high_JJ and_CC low_JJ
          antibody_NN responders_NNS ._. It_PRP was_VBD immediately_RB apparent_JJ that_IN the_DT
          β_NN coefficients_NNS from_IN PL_NNP were_VBD similar_JJ in_IN both_DT groups_NNS ,_,
          whereas_IN those_DT from_IN BOP_NNP and_CC F_NN score_NN were_VBD only_RB significant_JJ
          in_IN high_JJ responders_NNS and_CC those_DT from_IN PD_NNP were_VBD only_RB
          significant_JJ in_IN low_JJ responders_NNS ._. Comparison_NNP of_IN the_DT
          differences_NNS in_IN β_NN coefficients_NNS between_IN high_JJ and_CC low_JJ
          responders_NNS ,_, column_NN 4_CD (_( column_NN 2_CD -_: column_NN 3_LS )_) ,_, indicated_VBD
          relationships_NNS of_IN DMFT_NNP to_TO pocket_VB depth_NN that_WDT were_VBD
          significantly_RB different_JJ and_CC relationships_NNS of_IN DMFT_NNP to_TO F_NN
          score_NN that_WDT were_VBD almost_RB significantly_RB different_JJ ,_, p_NN =_SYM 0_CD ._. 062_CD
          (_( Table_NNP 4_CD ,_, column_NN 4_LS )_) ._.
          Stepwise_NNP regression_NN confirmed_VBD the_DT similar_JJ associations_NNS
          of_IN DMFT_NNP with_IN plaque_NN prevalence_NN in_IN both_DT high_JJ and_CC low_JJ IgG_NNP
          antibody_NN responders_NNS ,_, but_CC significant_JJ associations_NNS with_IN
          only_RB F_NN score_NN and_CC BOP_NNP prevalence_NN in_IN high_JJ responders_NNS and_CC
          with_IN only_RB PD_NNP and_CC age_NN in_IN low_JJ responders_NNS ._. In_IN high_JJ
          responders_NNS ,_, DMFT_NNP increased_VBD as_IN plaque_NN and_CC BOP_NNP prevalences_NNS
          increased_VBN and_CC fell_VBN as_IN fluoride_NN exposure_NN increased_VBD ._. The_DT
          equation_NN obtained_VBN was_VBD :_: DMFT_NNP =_SYM 4_CD ._. 60_CD +_NN 0_CD ._. 28_CD PL_NNP ±_NN 0_CD ._. 39_CD BOP_NNP -_:
          0_CD ._. 88_CD FScore_NNP (_( R_NN 2_CD =_SYM 0_CD ._. 51_CD ,_, F_NN statistic_NN =_SYM 10_CD ._. 75_CD ,_, p_NN <_NN
          0_CD ._. 0001_CD )_) ._. By_IN contrast_NN ,_, in_IN low_JJ responders_NNS ,_, DMFT_NNP increased_VBD
          with_IN plaque_NN prevalence_NN ,_, pocket_NN depth_NN and_CC age_NN ._. The_DT
          equation_NN was_VBD :_: DMFT_NNP =_SYM -_: 13_CD ._. 37_CD +_NN 4_CD ._. 58_CD PD_NNP ±_NN 0_CD ._. 27_CD Age_NNP ±_NN 0_CD ._. 30_CD
          PL_NNP (_( R_NN 2_CD =_SYM 0_CD ._. 26_CD ,_, F_NN statistic_NN =_SYM 7_CD ._. 41_CD ,_, p_NN <_NN 0_CD ._. 0003_CD )_) ._. Within_IN
          each_DT equation_NN ,_, the_DT constant_JJ and_CC the_DT respective_JJ β_NN
          coefficients_NNS were_VBD significant_JJ (_( p_NN <_NN 0_CD ._. 05_CD )_) ,_, except_IN for_IN
          the_DT β_NN coefficient_NN of_IN age_NN in_IN low_JJ responders_NNS (_( p_NN =_SYM 0_CD ._. 062_CD )_) ._.
          High_JJ responders_NNS receiving_VBG fluoridated_JJ drinking_NN water_NN for_IN
          all_DT 14_CD years_NNS of_IN childhood_NN (_( F_NN score_NN =_SYM 5_LS )_) ,_, had_VBD a_DT
          significantly_RB lower_JJR DMFT_NNP than_IN those_DT never_RB receiving_VBG
          fluoridated_JJ water_NN (_( F_NN score_NN =_SYM O_NNP )_) :_: DMFT_NNP =_SYM 7_CD ._. 50_CD ±_NN 4_CD ._. 52_CD
          (_( s_VBZ ._. d_SYM ._. )_) vs_NNS 11_CD ._. 60_CD ±_NN 4_CD ._. 06_CD (_( s_VBZ ._. d_SYM ._. )_) ;_: '_POS t_NN '_'' test_NN p_NN <_NN 0_CD ._. 04_CD ._. This_DT
          was_VBD not_RB true_JJ of_IN low_JJ responders_NNS in_IN whom_WP the_DT difference_NN
          between_IN F_NN score_NN 5_CD and_CC F_NN score_NN 0_CD was_VBD not_RB significant_JJ (_( DMFT_NNP
          =_SYM 9_CD ._. 33_CD ±_NN 5_CD ._. 72_CD vs_NNS 12_CD ._. 07_CD ±_NN 5_CD ._. 85_CD ;_: '_POS t_NN '_'' test_NN p_NN =_SYM 0_CD ._. 14_CD )_) ._.
          When_WRB antibody_NN was_VBD ignored_VBN in_IN stepwise_NN regression_NN
          (_( control_NN )_) ,_, DMFT_NNP increased_VBD with_IN age_NN ,_, PL_NNP and_CC BOP_NNP ,_, and_CC
          decreased_VBD with_IN F_NN score_NN :_: DMFT_NNP =_SYM -_: 2_CD ._. 11_CD +_NN 0_CD ._. 17_CD Age_NNP +_NN 0_CD ._. 25_CD PL_NNP
          +_NN 0_CD ._. 27_CD BOP_NNP -_: 0_CD ._. 39_CD FScore_NNP (_( R_NN 2_CD =_SYM 0_CD ._. 29_CD ,_, F_NN statistic_NN =_SYM 6_CD ._. 62_CD ,_,
          p_NN <_NN 0_CD ._. 0001_CD )_) ._. PL_NNP and_CC BOP_NNP were_VBD individually_RB significant_JJ ._.
          F_NN Score_NN and_CC age_NN were_VBD borderline_NN ,_, p_NN =_SYM 0_CD ._. 09_CD and_CC 0_CD ._. 14_CD
          respectively_RB ,_, and_CC PD_NNP was_VBD not_RB significant_JJ ,_, being_VBG entirely_RB
          replaced_VBN with_IN age_NN ._. Despite_IN the_DT subjects_NNS increasing_VBG to_TO 102_CD
          (_( from_IN 35_CD or_CC 67_CD )_) the_DT strength_NN of_IN association_NN was_VBD similar_JJ
          to_TO that_DT of_IN low_JJ responders_NNS only_RB ._.
        
        
          Association_NNP of_IN DT_NNP with_IN gingivitis_NNS in_IN high_JJ and_CC low_JJ
          responders_NNS
          Because_IN caries_NNS experience_VBP associated_VBN with_IN fluoride_NN and_CC
          gingival_NN health_NN in_IN high_JJ responders_NNS ,_, poor_JJ gingival_NN health_NN
          should_MD increase_VB the_DT number_NN of_IN decayed_JJ teeth_NNS (_( DT_NNP )_) more_JJR
          than_IN in_IN low_JJ responders_NNS ._. When_WRB BOP_NNP was_VBD regressed_JJ against_IN
          the_DT variables_NNS in_IN Table_NNP 5_CD ,_, only_RB DT_NNP (_( column_NN 4_LS )_) differed_VBD
          significantly_RB between_IN the_DT high_JJ and_CC low_JJ responders_NNS ._.
          Although_IN DT_NNP alone_RB significantly_RB correlated_JJ with_IN BOP_NNP in_IN
          both_DT response_NN groups_NNS (_( p_NN <_NN 0_CD ._. 01_CD )_) ,_, it_PRP associated_VBN with_IN
          BOP_NNP much_RB more_RBR strongly_RB in_IN high_JJ responders_NNS (_( R_NN 2_CD =_SYM 0_CD ._. 57_CD )_)
          than_IN in_IN low_JJ responders_NNS (_( R_NN 2_CD =_SYM 0_CD ._. 12_CD )_) ._. Fig_NNP ._. 3_LS shows_VBZ the_DT
          respective_JJ correlations_NNS ,_, and_CC also_RB the_DT patient_NN data_NN
          (_( filled_VBN circles_NNS )_) skewed_VBN by_IN few_JJ healthy_JJ subjects_NNS and_CC the_DT
          student_NN data_NN (_( unfilled_JJ circles_NNS )_) skewed_VBN by_IN few_JJ moderate_JJ
          and_CC no_DT severely_RB diseased_JJ subjects_NNS ._. Clearly_RB ,_, combining_VBG
          students_NNS and_CC patients_NNS strengthened_VBD the_DT respective_JJ
          associations_NNS (_( β_NN coefficients_NNS )_) ._. Stepwise_NNP regression_NN
          indicated_VBD that_IN ,_, excluding_VBG DT_NNP ,_, BOP_NNP associated_VBN with_IN PL_NNP and_CC
          PD_NNP similarly_RB (_( BOP_NNP =_SYM -_: 14_CD ._. 02_CD +_NN 0_CD ._. 42_CD PL_NNP +_NN 4_CD ._. 8_CD PD_NNP in_IN high_JJ
          responders_NNS and_CC BOP_NNP =_SYM -_: 11_CD ._. 07_CD +_NN 0_CD ._. 34_CD PL_NNP +_NN 4_CD ._. 10_CD PD_NNP in_IN low_JJ
          responders_NNS ;_: R_NN 2_CD =_SYM 0_CD ._. 40_CD and_CC 0_CD ._. 41_CD respectively_RB ;_: p_NN <_NN
          0_CD ._. 001_CD )_) ._. However_RB ,_, DT_NNP explained_VBD more_JJR variance_NN (_( BOP_NNP =_SYM -_: 1_CD ._. 46_CD
          +_NN 0_CD ._. 24_CD PL_NNP +_NN 0_CD ._. 95_CD DT_NNP ,_, R_NN 2_CD =_SYM 0_CD ._. 62_CD ,_, p_NN <_NN 0_CD ._. 001_CD )_) in_IN high_JJ
          responders_NNS ,_, and_CC less_JJR variance_NN (_( BOP_NNP =_SYM -_: 3_CD ._. 25_CD +_NN 0_CD ._. 41_CD PL_NNP +_NN
          0_CD ._. 33_CD DT_NNP ,_, R_NN 2_CD =_SYM 0_CD ._. 31_CD ,_, p_NN <_NN 0_CD ._. 001_CD )_) in_IN low_JJ responders_NNS ._.
          Influential_JJ points_NNS (_( outliers_NNS )_) ,_, whose_WP$ presence_NN might_MD
          have_VB affected_VBN the_DT strength_NN and_CC significance_NN of_IN these_DT
          complex_JJ regression_NN analyses_NNS ,_, were_VBD identified_VBN in_IN five_CD low_JJ
          responders_NNS and_CC two_CD high_JJ responders_NNS ._. When_WRB these_DT subjects_NNS
          were_VBD omitted_VBN ,_, the_DT respective_JJ regression_NN coefficients_NNS or_CC
          their_PRP$ significance_NN were_VBD little_RB changed_JJ ,_, indicating_VBG that_IN
          the_DT different_JJ ,_, partial_JJ ,_, linear_JJ regression_NN coefficients_NNS in_IN
          high_JJ or_CC low_JJ responders_NNS were_VBD not_RB artifacts_NNS of_IN influential_JJ
          or_CC outlying_JJ points_NNS ._.
        
      
      
        Discussion_NNP
        This_DT study_NN has_VBZ demonstrated_VBN that_IN IgG_NNP antibodies_NNS to_TO
        D-_NNP alanyl_NN LTA_NNP are_VBP widespread_JJ in_IN US_NNP adults_NNS ._. The_DT fraction_NN of_IN
        high_JJ responders_NNS was_VBD essentially_RB constant_JJ from_IN early_JJ
        adulthood_NN through_IN middle_JJ age_NN ,_, but_CC reduced_VBD in_IN children_NNS
        (_( <_NN 15_CD years_NNS )_) and_CC old_JJ age_NN (_( >_NN 55_CD years_NNS )_) ._. Within_IN the_DT
        adults_NNS (_( ages_NNS 15_CD -_: 55_CD years_NNS )_) a_DT change_NN from_IN low_JJ to_TO high_JJ
        response_NN or_CC 
        vice_NN versa_RB was_VBD found_VBN unlikely_JJ from_IN
        repeated_VBN measurements_NNS over_IN 2_CD -_: 6_CD months_NNS ._. A_DT similar_JJ lack_NN of_IN
        change_NN in_IN this_DT IgG_NNP antibody_NN concentration_NN was_VBD reported_VBN 2_CD -_: 3_CD
        months_NNS after_IN an_DT additional_JJ 26_CD similarly_RB aged_VBN patients_NNS had_VBD
        received_VBN oral_JJ hygiene_NN therapy_NN in_IN another_DT study_NN [_NN 32_CD ]_NN ._.
        Finally_RB ,_, the_DT family_NN studies_NNS established_VBN that_IN a_DT high_JJ
        antibody_NN response_NN was_VBD probably_RB induced_VBN during_IN the_DT
        mid-teenage_JJ years_NNS ._. In_IN order_NN to_TO apply_VB the_DT results_NNS of_IN this_DT
        study_NN to_TO children_NNS and_CC young_JJ teenagers_NNS ,_, longitudinal_NN studies_NNS
        of_IN the_DT antibody_NN response_NN in_IN relation_NN to_TO age_NN and_CC the_DT
        clinical_JJ measurements_NNS in_IN this_DT study_NN may_MD need_VB to_TO be_VB
        undertaken_VBN ._.
        Despite_IN few_JJ investigations_NNS of_IN caries_NNS risk_VBP in_IN 22_CD -_: 38_CD year_NN
        old_JJ subjects_NNS compared_VBN with_IN a_DT younger_JJR or_CC older_JJR group_NN [_NN 7_CD ]_NN ,_,
        the_DT association_NN of_IN DMFT_NNP with_IN PL_NNP in_IN this_DT study_NN agrees_VBZ with_IN
        that_DT obtained_VBD from_IN 35_CD year_NN old_JJ Norwegians_NNPS [_NN 3_CD ]_NN ._. Plaque_NNP
        (_( simplified_VBN oral_JJ hygiene_NN index_NN measurement_NN )_) accounted_VBD for_IN
        15_CD %_NN of_IN the_DT variance_NN in_IN number_NN of_IN decayed_JJ /_NN filled_VBD teeth_NNS
        surfaces_VBZ in_IN that_DT study_NN ,_, and_CC for_IN 19_CD %_NN of_IN the_DT DMFT_NNP variance_NN
        within_IN all_DT 151_CD clinically_RB examined_VBD subjects_NNS in_IN this_DT study_NN
        (_( ignoring_VBG age_NN ,_, antibody_NN and_CC all_DT other_JJ variables_NNS )_) ._. Other_JJ
        studies_NNS have_VBP shown_VBN that_IN the_DT amount_NN of_IN fluoride_NN applied_VBN from_IN
        dentrifices_NNS is_VBZ measured_VBN better_JJR from_IN oral_JJ hygiene_NN or_CC plaque_NN
        accumulation_NN ,_, as_IN in_IN this_DT study_NN ,_, and_CC not_RB from_IN the_DT reported_VBN
        frequency_NN of_IN dentrifice_NN use_NN [_NN 2_CD 3_CD ]_NN ._. Finally_RB ,_, because_IN
        subjects_NNS aged_VBN more_JJR than_IN 38_CD are_VBP unlikely_JJ to_TO have_VB used_VBN
        fluoridated_JJ toothpastes_NNS until_IN later_RB in_IN life_NN ,_, they_PRP were_VBD
        omitted_VBN to_TO avoid_VB confounding_VBG the_DT results_NNS ._.
        The_DT rationale_NN behind_IN this_DT study_NN was_VBD that_IN acidic_JJ plaque_NN
        environments_NNS increase_VBP the_DT amount_NN of_IN D-_NNP alanyl_NN LTA_NNP and_CC
        promote_VB its_PRP$ immunogenicity_NN ._. Accordingly_RB ,_, caries-protection_JJ
        by_IN fluoride_NN in_IN the_DT water_NN supply_NN and_CC dentrifices_NNS was_VBD strong_JJ
        in_IN high_JJ IgG_NNP antibody_NN responders_NNS ,_, accounting_NN for_IN just_RB over_IN
        50_CD %_NN of_IN the_DT variance_NN in_IN DMFT_NNP ._. In_IN addition_NN ,_, gingivitis_NNS (_( BOP_NNP
        prevalence_NN )_) associated_VBN strongly_RB and_CC significantly_RB with_IN the_DT
        number_NN of_IN decayed_JJ (_( untreated_JJ )_) teeth_NNS ,_, suggesting_VBG that_IN
        preventing_VBG gingivitis_NNS increased_VBD fluoride_NN exposure_NN from_IN
        dentrifices_NNS and_CC reduced_VBD the_DT number_NN of_IN decayed_JJ teeth_NNS ._.
        Increased_VBN exposure_NN to_TO fluoridated_JJ water_NN ,_, and_CC dentrifices_NNS
        associated_VBN with_IN good_JJ gingival_NN health_NN ,_, may_MD result_VB in_IN
        fluoride_NN inhibiting_VBG enamel_NN remineralization_NN at_IN the_DT acidic_JJ
        plaque_NN pH_NN likely_JJ present_NN in_IN high_JJ responders_NNS ._.
        In_IN low_JJ responders_NNS ,_, the_DT fewer_JJR antibodies_NNS to_TO D-_NNP alanyl_NN LTA_NNP
        suggest_VBP less_JJR colonization_NN by_IN acid-tolerant_JJ bacteria_NNS and_CC a_DT
        weaker_JJR cariogenic_JJ attack_NN ._. DMFT_NNP associated_VBN with_IN age_NN ,_, as_IN
        reported_VBN for_IN other_JJ subjects_NNS whose_WP$ sera_NN did_VBD not_RB precipitate_NN
        D-_NNP alanyl_NN LTA_NNP [_NN 22_CD ]_NN ,_, and_CC also_RB with_IN pocket_NN depth_NN ._. An_DT
        increase_NN in_IN pocket_NN depth_NN is_VBZ caused_VBN by_IN periodontopathic_JJ
        bacteria_NNS that_IN associate_JJ with_IN an_DT alkaline_NN environment_NN in_IN the_DT
        sulci_NN over_IN many_JJ years_NNS [_NN 20_CD ]_NN and_CC a_DT microbiota_NN that_WDT is_VBZ
        neither_DT acidic_JJ nor_CC acid-tolerant_JJ [_NN 10_CD ]_NN ._. The_DT coefficient_NN
        of_IN DMFT_NNP association_NN with_IN PD_NNP in_IN low_JJ responders_NNS therefore_RB
        differed_VBD significantly_RB from_IN high_JJ responders_NNS within_IN whom_WP F_NN
        score_NN and_CC gingival_NN health_NN were_VBD stronger_JJR covariates_NNS ._.
      
      
        Conclusions_NNP
        An_DT increased_VBN mutans_NNS streptococcal_NN challenge_NN accompanying_VBG
        low_JJ plaque_NN pH_NN (_( high_JJ antibody_NN response_NN to_TO D-_NNP alanyl_NN LTA_NNP )_)
        allows_VBZ much_JJ of_IN the_DT variation_NN in_IN caries_NNS experience_VBP to_TO be_VB
        controlled_VBN by_IN water_NN fluoridation_NN and_CC by_IN the_DT use_NN of_IN
        fluoridated_JJ dentrifices_NNS associated_VBN with_IN maintaining_VBG oral_JJ
        health_NN ._. High_NNP IgG_NNP antibody_NN responders_NNS are_VBP therefore_RB better_RBR
        protected_JJ from_IN caries_NNS in_IN an_DT optimally_RB fluoridated_JJ
        environment_NN ._. The_DT concept_NN that_DT fluoride_NN protects_VBZ better_JJR from_IN
        caries_NNS in_IN a_DT low_JJ pH_NN environment_NN [_NN 12_CD ]_NN was_VBD recently_RB used_VBN to_TO
        explain_VB why_WRB there_EX is_VBZ a_DT poor_JJ association_NN between_IN caries_NNS
        experience_VBP and_CC pH_NN fall_NN after_IN a_DT 10_CD %_NN sucrose_NN rinse_NN [_NN 33_CD ]_NN ._.
        In_IN low_JJ responders_NNS ,_, increased_VBN fluoride_NN exposure_NN from_IN
        dentriflce_NN use_NN to_TO maintain_VB oral_JJ health_NN ,_, or_CC from_IN water_NN
        fluoridation_NN ,_, associate_JJ relatively_RB poorly_RB with_IN caries_NNS
        experience_VBP ._. Although_IN this_DT study_NN has_VBZ indicated_VBN that_IN the_DT IgG_NNP
        antibodies_NNS to_TO D-_NNP alanyl_NN LTA_NNP do_VBP not_RB become_VB elevated_VBD until_IN
        after_IN age_NN 17_CD ,_, when_WRB much_JJ caries_NNS may_MD have_VB already_RB developed_VBN ,_,
        they_PRP may_MD be_VB elevated_VBD to_TO a_DT lower_JJR level_NN in_IN children_NNS who_WP
        eventually_RB become_VBP high_JJ responders_NNS ._. The_DT D-_NNP alanyl_NN LTA_NNP
        antibody_NN response_NN is_VBZ not_RB detectable_JJ in_IN saliva_NN (_( unpublished_JJ
        studies_NNS )_) ,_, but_CC it_PRP can_MD be_VB measured_VBN from_IN only_RB a_DT thumb-prick_JJ of_IN
        blood_NN ._. Longitudinal_NNP studies_NNS of_IN the_DT D-_NNP alanyl_NN LTA_NNP response_NN in_IN
        children_NNS could_MD improve_VB current_JJ efforts_NNS to_TO predict_VB caries_NNS
        susceptibility_NN by_IN relating_VBG it_PRP to_TO fluoride_NN or_CC the_DT fluoride_NN
        ion_NN product_NN for_IN fluoroapatite_NN in_IN saliva_NN and_CC the_DT pH_NN change_NN
        after_IN a_DT sucrose_NN rinse_NN [_NN 5_CD 12_CD 13_CD 33_CD ]_NN ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD
      
    
  
